SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-052856
Filing Date
2019-02-27
Accepted
2019-02-27 07:43:02
Documents
3
Period of Report
2019-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d710120d8k.htm 8-K 17315
2 EX-99.1 d710120dex991.htm EX-99.1 78007
3 GRAPHIC g710120g0227053916500.jpg GRAPHIC 2610
  Complete submission text file 0001193125-19-052856.txt   100307
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 19635830
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences